New evidence indicates that distinct mutations cause familial Parkinson's disease (PD) by mechanisms that may also operate in sporadic PD. These new data point to the importance of cell dysfunction preceding cell death and to the involvement of non-dopaminergic neurons in the disease. Accordingly, identifying mechanisms of cellular dysfunction that are common to multiple causes of PD may offer new therapeutic targets to halt or reverse the course of the disease. This renewal application for the UCLA UDALL Parkinson Disease Center of Excellence focuses on studies of progression of dysfunction, in complementary models expressing PD-causing mutations, and in a well characterized patient population. The center consists of 5 projects supported by an administrative core and a mouse genetics core. In the first three projects we propose to continue coordinated multidisciplinary work supported by the current award to characterize the progression of motor and non-motor behavioral anomalies and neuropathology (project 1), anomalies of neurotransmitter release (project 2) and of synaptic function (project 3) in genetic mouse models of PD, including novel models based on BAG technology. These projects will be complemented by the addition of cellular models (project 4) to analyze the mechanisms of cellular dysfunction leading to the phenotypes observed in the mouse. Studying progression of dysfunction will also be the focus of the new patient oriented component of the Center. In this project (project 5), we will conduct clinical longitudinal studies of disease phenotype after diagnosis, including psychiatric and cognitive co-morbidities. This will be coupled to the development and validation of an improved health-related quality of life assessment tool. These patient oriented studies will provide crucial clinical data for future analyses of genetic material from the same patients and for the translation of our basic research efforts into improved patient care. To identify the cellular alterations leading to neurodegeneration in PD, the UCLA UDALL Parkinson Disease Center of Excellence will focus on early manifestations of the disease occurring before the onset of motor symptoms and their progression. Integrating experimental models and clinical studies, the goal of our center is to understand the mechanisms of these cellular dysfunctions in order to spur the development of therapeutic strategies able to stop the disease process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
3P50NS038367-10S3
Application #
8322208
Study Section
Special Emphasis Panel (ZNS1-SRB-M (29))
Program Officer
Sieber, Beth-Anne
Project Start
2000-08-01
Project End
2012-04-30
Budget Start
2010-08-15
Budget End
2012-04-30
Support Year
10
Fiscal Year
2011
Total Cost
$112,420
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Mata, Ignacio F; Leverenz, James B; Weintraub, Daniel et al. (2016) GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Mov Disord 31:95-102
Lee, P C; Bordelon, Y; Bronstein, J et al. (2015) Head injury, α-synuclein genetic variability and Parkinson's disease. Eur J Neurol 22:874-8
Srivatsal, Sindhu; Cholerton, Brenna; Leverenz, James B et al. (2015) Cognitive profile of LRRK2-related Parkinson's disease. Mov Disord 30:728-33
Nielsen, Malene; Hansen, Johnni; Ritz, Beate et al. (2014) Cause-specific mortality among spouses of Parkinson disease patients. Epidemiology 25:225-32
Burdick, Daniel J; Cholerton, Brenna; Watson, G S et al. (2014) People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 29:1258-64
Liew, Zeyan; Wang, Anthony; Bronstein, Jeff et al. (2014) Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease. Arch Environ Occup Health 69:241-51
Richter, Franziska; Fleming, Sheila M; Watson, Melanie et al. (2014) A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics 11:840-56
Richter, Franziska; Gao, Fuying; Medvedeva, Vera et al. (2014) Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons. Neurobiol Dis 69:263-75
Fitzmaurice, Arthur G; Rhodes, Shannon L; Cockburn, Myles et al. (2014) Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Neurology 82:419-26
McDowell, Kimberly A; Shin, David; Roos, Kenneth P et al. (2014) Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein. J Parkinsons Dis 4:531-9

Showing the most recent 10 out of 107 publications